Showing 1 - 10 of 1,606
Persistent link: https://www.econbiz.de/10003386142
Persistent link: https://www.econbiz.de/10002595503
expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … utilization in Sweden, so the cost per life-year gained from the introduction of new drugs was quite low. -- longevity … ; pharmaceutical ; innovation ; drugs ; Sweden …
Persistent link: https://www.econbiz.de/10009571756
Persistent link: https://www.econbiz.de/10010492492
Persistent link: https://www.econbiz.de/10010345456
Persistent link: https://www.econbiz.de/10010345585
pharmaceuticals to examine how incumbents respond to change in the threat of entry. In line with the entry deterrence motive …
Persistent link: https://www.econbiz.de/10012285099
pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012103333
pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012119750
Persistent link: https://www.econbiz.de/10003739056